We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+54.77%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$388M
AUM Growth
+$65.3M
(+20%)
Cap. Flow
-$1.56M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
82.04%
Holding
61
New
5
Increased
9
Reduced
7
Closed
18
Top Buys
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$81.6M |
| 2 |
Cigna
CI
|
+$17M |
| 3 |
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
|
+$13.3M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$8.2M |
| 5 |
Protagonist Therapeutics
PTGX
|
+$3.71M |
Top Sells
| 1 |
GE HealthCare
GEHC
|
+$16.5M |
| 2 |
BCYC
Bicycle Therapeutics
BCYC
|
+$16M |
| 3 |
Pfizer
PFE
|
+$14.9M |
| 4 |
Organon & Co
OGN
|
+$13.3M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$12.6M |
Sector Composition
| 1 | Healthcare | 99.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $85.3M | 21.96% |
+1,451,925
| New | +$81.6M |
|
|
GRCL
2
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $50.2M | 12.93% |
5,001,580
+2,920,364
| +140% | +$13.3M |
|
3
Labcorp
LH
$22.6B
| $37.5M | 9.66% |
165,123
-3,686
| -2% | -$774K |
|
|
4
Cigna
CI
$80.2B
| $34.9M | 8.99% |
116,553
+58,327
| +100% | +$17M |
|
5
Globus Medical
GMED
$10.3B
| $28.4M | 7.3% |
532,089
+15,108
| +3% | +$736K |
|
6
GSK
GSK
$103B
| $21.2M | 5.45% |
571,391
+62,391
| +12% | +$2.24M |
|
|
IMGN
7
DELISTED
Immunogen Inc
IMGN
| $19.1M | 4.92% |
644,366
+411,615
| +177% | +$8.2M |
|
8
United Therapeutics
UTHR
$22.4B
| $17.6M | 4.53% |
80,050
-1,556
| -2% | -$359K |
|
9
Embecta
EMBC
$184M
| $13.9M | 3.59% |
736,008
+167,714
| +30% | +$2.75M |
|
|
10
Protagonist Therapeutics
PTGX
$8.44B
| $10.5M | 2.72% |
460,044
+211,917
| +85% | +$3.71M |
|
11
Teleflex
TFX
$5.76B
| $9.11M | 2.34% |
36,527
-27,964
| -43% | -$5.98M |
|
12
Zimmer Biomet
ZBH
$17.6B
| $8.8M | 2.27% |
72,300
-1,100
| -1% | -$123K |
|
13
Healthcare Services Group
HCSG
$1.65B
| $8.4M | 2.16% |
810,307
| – | – |
|
14
ARS Pharmaceuticals
SPRY
$756M
| $6.06M | 1.56% |
1,105,911
| – | – |
|
15
BridgeBio Pharma
BBIO
$16.5B
| $5.32M | 1.37% |
131,753
-91,194
| -41% | -$2.74M |
|
16
Ocular Therapeutix
OCUL
$2.12B
| $4.33M | 1.12% |
+971,446
| New | +$2.87M |
|
|
MACK
17
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $3.87M | 1% |
288,466
| – | – |
|
|
HARP
18
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $3.39M | 0.87% |
297,936
+129,919
| +77% | +$1.02M |
|
19
X4 Pharmaceuticals
XFOR
$379M
| $3.01M | 0.77% |
119,614
+32,981
| +38% | +$802K |
|
|
FUSN
20
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $2.36M | 0.61% |
246,036
| – | – |
|
|
CMPS
21
Compass Pathways
CMPS
$1.81B
| $2.2M | 0.57% |
+251,532
| New | +$1.63M |
|
22
Arcutis Biotherapeutics
ARQT
$3.35B
| $2.05M | 0.53% |
635,969
| – | – |
|
|
THRD
23
DELISTED
Third Harmonic Bio
THRD
| $1.79M | 0.46% |
+163,363
| New | +$1.29M |
|
24
Prelude Therapeutics
PRLD
$350M
| $1.37M | 0.35% |
320,394
-29,606
| -8% | -$90.1K |
|
25
Aprea Therapeutics
APRE
$9.02M
| $1.32M | 0.34% |
280,000
| – | – |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA